Brazil Animal Health Market Size, Share and Outlook - Growth Analysis Report and Forecast Trends 2026-2030

Brazil is Latin America's largest animal health market, supplying medicines, vaccines, diagnostics, and nutritional products for cattle, poultry, swine, and a fast-growing companion-animal population. The market is currently valued at about USD 2.33 billion in 2025 and is forecast to expand at a compound annual growth rate of roughly 7.9%, reflecting both production-animal volume and higher-value pet care spending. Domestic trade body SINDAN reported veterinary industry net revenue rising from R$ 10.4 billion in 2022 to R$ 11.9 billion in 2024, while the wider animal health sector closed 2025 at a record R$ 12.8 billion. The market sits within one of the world's most important livestock-producing nations, where animal health is directly tied to export competitiveness in beef, poultry, and pork.

• •Latin America's largest animal health market, valued at ~USD 2.33 billion in 2025
• •Forecast CAGR of approximately 7.9% through the early 2030s
• •SINDAN-reported veterinary industry revenue grew ~10.5% in 2024 to R$ 11.9 billion
• •Brazil is the world's largest beef exporter and a leading poultry and pork producer

Demand is anchored by Brazil's livestock export trajectory, where healthier herds and flocks are essential for meeting sanitary requirements in markets such as China, the EU, and the Middle East. On the companion side, pet ownership has risen sharply, with pets now representing roughly 27% of veterinary industry volume versus about 15% in 2014. Recurring disease pressure from foot-and-mouth disease, avian influenza, classical swine fever, and tick-borne conditions keeps vaccine and pharmaceutical usage structurally high. At the same time, premiumization of pet care, increased veterinary clinic penetration, and heightened awareness of zoonotic and foodborne risks are lifting per-animal spend.

• •Protein export demand drives intensive use of vaccines, parasiticides, and antibiotics in cattle, poultry, and swine
• •Pet healthcare share of the industry rose from ~15% (2014) to ~27% (2024)
• •Persistent endemic diseases (FMD, AI, swine fever, ticks) sustain baseline pharmaceutical demand
• •Rising household pet ownership and disposable income support premium nutrition and therapeutic products

The market is typically segmented by animal type into production animals (cattle, poultry, swine) and companion animals (dogs, cats, others), and by product into pharmaceuticals, biologics/vaccines, medicated feed additives, and diagnostics. Pharmaceuticals and vaccines together account for the bulk of revenue, with vaccines gaining share as Brazil's MAPA-driven eradication and control programs expand. Regionally, the Southeast and South host the largest demand pools because of higher concentrations of beef and dairy herds, integrated poultry and swine operations, and major urban pet populations in cities such as São Paulo, Rio de Janeiro, Porto Alegre, and Curitiba. The Center-West (Mato Grosso, Goiás) is a high-growth production-animal pocket driven by beef expansion, while the Northeast remains comparatively underpenetrated.

• •Production animals dominate volume; companion animals lead growth and margin expansion
• •Vaccines and parasiticides are the strongest product sub-categories
• •Southeast and South regions are largest markets; Center-West is fastest-growing production segment
• •Urban centers (São Paulo, Rio, Porto Alegre, Curitiba) drive companion-animal sales

What are the recent trends and outlook?

Three structural trends are reshaping the market through 2030: biologics innovation (recombinant and mRNA veterinary vaccines, broader poultry and swine portfolios), precision livestock tools (digital health monitoring, diagnostics-linked therapeutics), and continued premiumization of pet care (specialty diets, dermatology, parasiticide regimens). Regulatory tightening on antibiotic use is accelerating the shift toward vaccines, immune modulators, and alternative therapies, which supports biologics growth above the market average. With production-animal demand tied to export cycles and companion-animal spend tracking urbanization and middle-class expansion, Brazil's animal health market is positioned to sustain mid-to-high single-digit growth, comfortably outpacing most neighboring Latin American markets.

• •Shift from antibiotics toward vaccines, immune modulators, and diagnostics-driven herd health management
• •Adoption of precision livestock technologies and digital health monitoring on commercial farms
• •Continued premiumization of pet care, including specialty nutrition and chronic-condition therapeutics
• •Long-term growth expected to remain in the high single digits, supported by export and pet-sector tailwinds